135 related articles for article (PubMed ID: 7713893)
1. Comparison of the DNA binding specificity and function of v-ErbA and thyroid hormone receptor alpha 1.
Subauste JS; Koenig RJ
J Biol Chem; 1995 Apr; 270(14):7957-62. PubMed ID: 7713893
[TBL] [Abstract][Full Text] [Related]
2. Identification of DNA binding sites for the V-erbA oncoprotein, the viral homolog to thyroid hormone receptor alpha.
Harbers M; Wahlström GM; Vennström B
J Steroid Biochem Mol Biol; 1998 Nov; 67(3):181-91. PubMed ID: 9879977
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the DNA-binding and dominant negative activity of v-erbA homodimers.
Subauste JS; Koenig RJ
Mol Endocrinol; 1998 Sep; 12(9):1380-92. PubMed ID: 9731706
[TBL] [Abstract][Full Text] [Related]
4. A choice between transcriptional enhancement and repression by the v-erbA oncoprotein governed by one nucleotide in a thyroid hormone responsive half site.
Andersson ML; Vennström B
Oncogene; 2000 Jul; 19(32):3563-9. PubMed ID: 10951561
[TBL] [Abstract][Full Text] [Related]
5. The oncoprotein P75gag-v-erbA represses thyroid hormone induced transcription only via response elements containing palindromic half-sites.
Wahlström GM; Harbers M; Vennström B
Oncogene; 1996 Aug; 13(4):843-52. PubMed ID: 8761306
[TBL] [Abstract][Full Text] [Related]
6. Thyroid hormone receptor/and v-erbA. A single amino acid difference in the C-terminal region influences dominant negative activity and receptor dimer formation.
Selmi S; Samuels HH
J Biol Chem; 1991 Jun; 266(18):11589-93. PubMed ID: 1675637
[TBL] [Abstract][Full Text] [Related]
7. DNA recognition by normal and oncogenic thyroid hormone receptors. Unexpected diversity in half-site specificity controlled by non-zinc-finger determinants.
Judelson C; Privalsky ML
J Biol Chem; 1996 May; 271(18):10800-5. PubMed ID: 8631892
[TBL] [Abstract][Full Text] [Related]
8. Myb-Ets fusion oncoprotein inhibits thyroid hormone receptor/c-ErbA and retinoic acid receptor functions: a novel mechanism of action for leukemogenic transformation by E26 avian retrovirus.
Rascle A; Ferrand N; Gandrillon O; Samarut J
Mol Cell Biol; 1996 Nov; 16(11):6338-51. PubMed ID: 8887663
[TBL] [Abstract][Full Text] [Related]
9. A conserved C-terminal sequence that is deleted in v-ErbA is essential for the biological activities of c-ErbA (the thyroid hormone receptor).
Saatcioglu F; Bartunek P; Deng T; Zenke M; Karin M
Mol Cell Biol; 1993 Jun; 13(6):3675-85. PubMed ID: 8098843
[TBL] [Abstract][Full Text] [Related]
10. V-erbA requires auxiliary proteins for dominant negative activity.
Hermann T; Hoffmann B; Piedrafita FJ; Zhang XK; Pfahl M
Oncogene; 1993 Jan; 8(1):55-65. PubMed ID: 8093812
[TBL] [Abstract][Full Text] [Related]
11. Leukemic transformation by the v-ErbA oncoprotein entails constitutive binding to and repression of an erythroid enhancer in vivo.
Ciana P; Braliou GG; Demay FG; von Lindern M; Barettino D; Beug H; Stunnenberg HG
EMBO J; 1998 Dec; 17(24):7382-94. PubMed ID: 9857194
[TBL] [Abstract][Full Text] [Related]
12. Constitutive transactivation by the thyroid hormone receptor and a novel pattern of activity of its oncogenic homolog v-ErbA in Xenopus oocytes.
Nagl SB; Nelson CC; Romaniuk PJ; Allison LA
Mol Endocrinol; 1995 Nov; 9(11):1522-32. PubMed ID: 8584030
[TBL] [Abstract][Full Text] [Related]
13. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
Damm K; Evans RM
Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of transformation by v-ErbA: substitution for steroid hormone receptor function in self renewal induction.
Bauer A; Ulrich E; Andersson M; Beug H; von Lindern M
Oncogene; 1997 Aug; 15(6):701-15. PubMed ID: 9264411
[TBL] [Abstract][Full Text] [Related]
15. The lack of transcriptional activation of the v-erbA oncogene is in part due to a mutation present in the DNA binding domain of the protein.
de Verneuil H; Metzger D
Nucleic Acids Res; 1990 Aug; 18(15):4489-97. PubMed ID: 1975094
[TBL] [Abstract][Full Text] [Related]
16. Thyroid hormone receptor transcriptional activity is potentially autoregulated by truncated forms of the receptor.
Bigler J; Hokanson W; Eisenman RN
Mol Cell Biol; 1992 May; 12(5):2406-17. PubMed ID: 1314955
[TBL] [Abstract][Full Text] [Related]
17. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
Wahlström GM; Vennström B
Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
[TBL] [Abstract][Full Text] [Related]
18. A domain containing leucine-zipper-like motifs mediate novel in vivo interactions between the thyroid hormone and retinoic acid receptors.
Forman BM; Yang CR; Au M; Casanova J; Ghysdael J; Samuels HH
Mol Endocrinol; 1989 Oct; 3(10):1610-26. PubMed ID: 2558297
[TBL] [Abstract][Full Text] [Related]
19. Sequences required for the transition from monomeric to homodimeric forms of thyroid hormone receptor alpha and v-erbA.
Zubkova I; Subauste JS
Mol Cell Endocrinol; 2003 Jan; 199(1-2):61-72. PubMed ID: 12581880
[TBL] [Abstract][Full Text] [Related]
20. The effect of oncoprotein v-erbA on thyroid hormone-regulated genes in hepatocytes and their potential role in hepatocellular carcinoma.
Ventura-Holman T; Mamoon A; Subauste MC; Subauste JS
Mol Biol Rep; 2011 Feb; 38(2):1137-44. PubMed ID: 20571909
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]